ALC News and Press, Alcon Inc. From 01/12/22

Clinically proven to relieve all types of dry eye, 1 Systane Complete is now preservative-free and available in a multi-dose bottle Joins the fast-growing, preservative-free segment of artificial tears, representing over 40% of the global category 2 A...

The first and only Water Gradient contact lens for patients with astigmatism, available in the U.S. beginning in March DAILIES TOTAL1 for Astigmatism joins DAILIES TOTAL1 sphere and multifocal for a full portfolio designed for the premium, daily disposable lens market ...

Alcon will leverage its global footprint and leadership in ophthalmology to drive future growth, bringing this innovative device to more patients worldwide Ivantis associates, including manufacturing and sales, are immediately integrated into Alcon to ensure continuity for n...

Wedgewood Partners’ 13F portfolio value increased ~3% from ~$690M to ~$709M this quarter. They added UnitedHealth and increased Taiwan Semi while reducing Starbucks, Keysight Technologies, and Alphabet. Their top five positions are at 37% of the overall portfolio. For...

Alcon has built a leading position over time in the surgical and vision care markets. This is a high-quality business with predictive cash flows fitting the value framework. On the back of strong results, I have raised ALC's fair value from roughly $61.00 per share to approximately $7...

PRECISION1 is the first mainstream daily disposable contact lens to use SMARTSURFACE Technology to deliver lasting visual performance and comfort 1 Available in Europe, PRECISION1 for Astigmatism features the proven PRECISION BALANCE 8|4 lens design for a stable contact lens-w...

The following slide deck was published by Alcon Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Alcon Inc. 2021 Q3 - Results - Earnings Call Presentation

Image source: The Motley Fool. Alcon inc (NYSE: ALC) Q3 2021 Earnings Call Nov 10, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Alcon inc (ALC) Q3 2021 Earnings Call Transcript

Alcon Inc. (ALC) Q3 2021 Results Conference Call November 10, 2021 8:00 AM ET Company Participants David Endicott – Chief Executive Officer Tim Stonesifer – Chief Financial Officer Karen King – Senior Vice President, Head of Global Corporate Affairs and IR Conference Call...

Alcon (NYSE:ALC) swung to net income of $2M in Q3 2021 from a loss of $147M in prior-year due in part to a boost in sales in its surgical business. Sales in that division were ~1.2B, a ~17% increase compared to Q3 2020. Vision care sales rose ~12% to $923M. R&D expenses increased 47% to 3...